Related Articles
Early response to interferon α treatment and long-term clinical outcome in Japanese patients with chronic HBV genotype C infection
Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-α
Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy
Predictive value of plasmacytoid dendritic cells and Toll‑like receptor‑9 regarding the treatment efficacy of interferon‑α in HBeAg‑positive chronic hepatitis B patients
Predominance of precore mutations and clinical significance of basal core promoter mutations in chronic hepatitis B virus infection in Indonesia